Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5) Peptid
CHRNA5
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN974953
Kurzübersicht für Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5) Peptid (ABIN974953)
Target
CHRNA5
(Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-CHRNA5 antibody (Catalog #: ARP34967_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CHRNA5 (Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5))
-
Hintergrund
-
Nicotinic acetylcholine receptors (nAChRs), such as CHRNA5, are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be (hetero)pentamers composed of homologous subunits.
Alias Symbols: LNCR2
Protein Interaction Partner: CHRNB4
Protein Size: 468 -
Molekulargewicht
- 53 kDa
-
Gen-ID
- 1138
-
NCBI Accession
- NM_000745, NP_000736
-
UniProt
- P30532
Target
-
Sie sind hier:
